MDR Compact Inhalator USB Rechargeable Ultrasonic Nebulizador Portatil Quiet Inhaler Mesh Portable Nebulizer

Description

Shenzhen Fitconn Technology Co.,ltd was founded in 2012 . It is a comprehensive enterprise dedicated to the research and development, manufacturing, sales and after-sales service of household medical products. The products cover nebulizer (compressor nebulizer, DC Compressor nebulizer and Mesh nebulizer), anti-decubitus air mattress, oximeters, fetal doppler, blood pressure monitors, etc. The business covers more than 150 countries around the world, with an average annual service of more than 2,000,000 family. Fitconn adheres to the concept of create health by heart, and is committed to improving the diversification of atomization methods, let’s households medical products and modern medical technology can benefit thousands of families around the world, with respect, tolerance, integrity, efficiency, innovation and persistence as core values, Integrate superior resources, take innovation as the source of development, and take science and technology as the foundation of success, and strive to provide each consumer with more professional, advanced and safer medical products. Fitconn has the class II medical device production qualification and over 50 patents , the company has passed the 13485 quality system certification, and some products have passed the EU CE and FDA certification

Fitconn MY-132: The Quietest Nebulizer You Will Ever Use

There is a number on the Fitconn MY-132 spec sheet that deserves its own paragraph: 25 dB. Not 50. Not 40. Twenty-five. That is quieter than a whisper, quieter than a library at midnight, quieter than the ambient hum of a room with the lights turned off. It is the kind of quiet that makes you check whether the device is actually running. And for a nebulizer — a device whose entire purpose is to deliver medication over a sustained period while the patient sits still and breathes — that quietness is not a specification. It is the feature that makes every other feature possible.

The Fitconn MY-132 is a mesh nebulizer built around a single, uncompromising premise: respiratory treatment should not announce itself to the room. It should happen silently, discreetly, and without disrupting the life that continues around it.

The Acoustic Engineering of Near-Silence

Most portable nebulizers advertise noise levels in the 45 to 55 dB range — quiet enough for general use, but still audible, still present, still a reminder that a medical device is running in the corner. The MY-132, at 25 dB, operates below the threshold of most ambient indoor environments. A ticking clock is louder. A refrigerator across the room is louder. The sound of your own breathing is often louder. This is not merely a reduction in volume. It is a qualitative shift in how the device integrates into daily life.

For parents treating children at night, this means the nebulizer does not wake siblings in the same room. For office workers managing chronic conditions during work hours, it means treatment can happen at a desk without drawing attention from colleagues. For travelers in shared accommodations, it means the device can run in a hostel dormitory or a hotel room without disturbing anyone. The MY-132 does not ask for a quiet room. It creates one.

Microporous Atomization: Fine Mist, Deep Lungs

The quietness is paired with clinical performance that justifies the medical-grade classification. The MY-132 uses microporous nebulization technology to produce particles with a Mass Median Aerodynamic Diameter of less than 5 micrometers — the clinical band where bronchial and pulmonary medications achieve optimal absorption. The nebulization rate holds steady at ≥0.2 mL per minute, with a medication capacity of up to 10 mL — enough for extended treatment cycles without refilling.

The device operates at approximately 110 KHz — an ultrasonic frequency calibrated to shear liquid medication into uniform droplets without the heat or pressure of mechanical compression. The result is a cool, consistent mist that deposits medication where it needs to go without irritating sensitive airways.

Automatic Cleaning: The Three-Second Ritual

Mesh nebulizers have a well-documented weakness: the mesh plate can clog with crystallized medication residue, reducing output and shortening the device's effective life. The MY-132 addresses this with an automatic cleaning function activated by a simple three-second long press of the power button. The user fills the medication cup with clean water, holds the button, and the device runs a rinse cycle that clears residual deposits from the mesh.

This is not a deep-clean replacement — periodic manual cleaning is still recommended — but it is the difference between a mesh that degrades in months and one that maintains consistent performance for the full duration of its service life. For a device with a one-year warranty, this feature is the reason the warranty is more than a formality. It is a realistic projection of how long the device will actually last with normal use.

Dual Power, Zero Compromise

The MY-132 runs on either two AA batteries or USB cable — a dual-power architecture that eliminates the anxiety of a dead battery in a moment of need. The included USB cable provides power from any standard source: laptop, power bank, car adapter, or wall outlet. The AA battery option means the device works even when electricity is unavailable — during power outages, in remote locations, or simply when the USB cable has been misplaced.

The 1.5W power consumption is remarkably low, meaning a set of quality AA batteries delivers multiple treatment cycles before replacement. The LED indicator lights provide clear status feedback — power on, treatment in progress, battery low — without requiring a complex display interface.

The Clinical Indications That Matter

The MY-132 is indicated for a comprehensive range of respiratory conditions: asthma, acute laryngitis, bronchiolitis, wheezing pneumonia, acute wheezing in infants and young children, chronic lung disease in premature infants, acute and chronic cough, mycoplasma pneumonia, and upper respiratory tract infections. For acute laryngitis in children, nebulization is specifically noted as effective in reducing laryngeal edema.

This is not a single-condition device. It is a general-purpose respiratory therapy tool that covers the majority of conditions for which home nebulization is clinically indicated.

The MDR Certification That Opens Europe

The MY-132 carries MDR EU certification — the updated European Medical Device Regulation that replaced the older MDD framework. MDR compliance is significantly more rigorous than its predecessor, requiring enhanced clinical evidence, post-market surveillance, and quality management documentation. For a handheld mesh nebulizer to hold MDR certification means the manufacturer has invested in the regulatory infrastructure to meet Europe's highest medical device standards.

This is reinforced by additional certifications: CE, SGS, NQA, and 93/42/EEC. The supplier — Shenzhen Fitconn Technology Co., Ltd. — is TÜV Rheinland verified, holds ISO 13485 quality management certification, and ranks as the number one leading factory for household medical devices on the platform. With 21 years of manufacturing experience, a 4.9 out of 5 store rating, and a 23% reorder rate across over 3,300 buyer reviews, Fitconn has the track record to support the quality claims that its certifications imply.

Who Should Carry This Product

The MY-132 is the right choice for a distributor targeting the premium home healthcare segment — buyers who are willing to pay for a nebulizer that does not feel like a medical device. It is the right choice for a retail channel where discretion and quietness are valued as highly as clinical performance — where a nebulizer that runs at 25 dB is a product that sells itself to anyone who has ever been woken up by a noisy compressor at 2 AM.

It is also the right choice for any buyer who understands that in respiratory therapy, adherence is the single biggest variable in treatment outcomes. And the biggest barrier to adherence is not the medication, or the diagnosis, or the cost. It is the inconvenience and disruption of the treatment itself. A nebulizer that runs at 25 dB removes that barrier. It makes treatment something that happens in the background of life rather than an event that interrupts it.

Available with customized logo, packaging, and graphic design at 1,000 pieces MOQ, the MY-132 is positioned as a premium portable nebulizer that justifies its place in a product line through a single, irrefutable specification: it is the quietest nebulizer most patients will ever use.

The Final Word

The Fitconn MY-132 does not compete on the number of features it offers. It competes on the number of decibels it does not produce. At 25 dB, it is not merely quiet. It is invisible. And in a market where most nebulizers announce their presence with mechanical noise, the one that disappears into silence is the one that patients actually want to live with.